日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Novel Pan-ALDH Inhibitor KS100 Effectively Targets ALDH+/CD138⁻ Stem-like Cells to Overcome Relapse in Multiple Myeloma

新型泛ALDH抑制剂KS100有效靶向ALDH+/CD138⁻干细胞样细胞,克服多发性骨髓瘤复发

Chitren, Robert; Gowda, Krishne; Amin, Shantu; Robertson, Gavin P; Jonnalagadda, Subash; Budak-Alpdogan, Tulin; Pandey, Manoj K

Development of a novel Bruton's tyrosine kinase inhibitor that exerts anti-cancer activities potentiates response of chemotherapeutic agents in multiple myeloma stem cell-like cells

开发一种具有抗癌活性的新型布鲁顿酪氨酸激酶抑制剂可增强多发性骨髓瘤干细胞样细胞对化疗药物的反应

Weam Othman Elbezanti, Omar S Al-Odat, Robert Chitren, Jaikee Kumar Singh, Sandeep Kumar Srivastava, Krishne Gowda, Shantu Amin, Gavin P Robertson, Venkatesh V Nemmara, Subash C Jonnalagadda, Tulin Budak-Alpdogan, Manoj K Pandey

Bruton's Tyrosine Kinase Targeting in Multiple Myeloma

布鲁顿酪氨酸激酶靶向治疗多发性骨髓瘤

Von Suskil, Max; Sultana, Kazi Nasrin; Elbezanti, Weam Othman; Al-Odat, Omar S; Chitren, Robert; Tiwari, Amit K; Challagundla, Kishore B; Srivastava, Sandeep Kumar; Jonnalagadda, Subash C; Budak-Alpdogan, Tulin; Pandey, Manoj K

Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma

Mcl-1抑制:多发性骨髓瘤恶性肿瘤的治疗

Al-Odat, Omar; von Suskil, Max; Chitren, Robert; Elbezanti, Weam; Srivastava, Sandeep; Budak-Alpddogan, Tulin; Jonnalagadda, Subash; Aggarwal, Bharat; Pandey, Manoj

Synthesis, in vitro, and in vivo evaluation of novel N-phenylindazolyl diarylureas as potential anti-cancer agents

新型N-苯基吲唑基二芳基脲类化合物的合成、体外和体内评价及其作为潜在抗癌药物的活性

Solano, Lucas N; Nelson, Grady L; Ronayne, Conor T; Jonnalagadda, Shirisha; Jonnalagadda, Sravan K; Kottke, Kaija; Chitren, Robert; Johnson, Joseph L; Pandey, Manoj K; Jonnalagadda, Subash C; Mereddy, Venkatram R